Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide

Stephen V. Liu, Tony S.K. Mok, Barzin Y. Nabet, Aaron S. Mansfield, Richard De Boer, György Losonczy, Shunichi Sugawara, Rafal Dziadziuszko, Maciej Krzakowski, Alexey Smolin, Maximilian J. Hochmair, Marina C. Garassino, Carl M. Gay, John V. Heymach, Lauren A. Byers, Sivuonthanh Lam, Andrés Cardona, Stefanie Morris, Leah Adler, David S. ShamesMartin Reck

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide'. Together they form a unique fingerprint.

Medicine & Life Sciences